发明名称 Dosage form to increase prasterone bioavailability
摘要 A way to formulate prasterone to both increase its oral bioavailability, and decrease the variability of its oral bioavailability.; In contrast to the approach taught by the prior art, the instant approach is amenable to scale-up to commercial scale. Further, the resulting product is amenable to analysis using standard, known quantitative analytical techniques; thus, unlike the prior art approach, the instant approach may be used to manufacture a product in conformity with applicable regulatory standards.
申请公布号 US8900631(B2) 申请公布日期 2014.12.02
申请号 US201213453987 申请日期 2012.04.23
申请人 Health Science Funding, LLC 发明人 Pohl J. Mark
分类号 A61K9/48;A61K31/5685;C07J1/00;A61K9/14 主分类号 A61K9/48
代理机构 Pharmaceutical Patent Attorneys, LLC 代理人 Pharmaceutical Patent Attorneys, LLC
主权项 1. A soft gelatin capsule suitable for oral administration, said soft gelatin capsule comprising: A. a soft gelatin capsule, and B. a fill, i. said fill consisting essentially of a durable oil vehicle, andii. at least about 100 milligrams of prasterone, and C. said soft gelatin capsule further having an outer lubricant coating.
地址 Morristown NJ US